4.4 Article

Risk of COVID-19 Among Unvaccinated and Vaccinated Patients With Rheumatoid Arthritis: A General Population Study

Journal

ARTHRITIS CARE & RESEARCH
Volume 75, Issue 5, Pages 956-966

Publisher

WILEY
DOI: 10.1002/acr.25028

Keywords

-

Categories

Ask authors/readers for more resources

Patients with rheumatoid arthritis (RA) are at higher risks of SARS-CoV-2 infection and severe outcomes even after COVID-19 vaccination. It is necessary to implement booster COVID-19 vaccinations and other preventive strategies for patients with RA.
ObjectiveTo determine whether patients with rheumatoid arthritis (RA) are at higher risks for SARS-CoV-2 infection and its severe outcomes before and after COVID-19 vaccination. MethodsUsing a UK primary care database, we conducted 2 cohort studies to compare the risks of SARS-CoV-2 infection, hospitalization, and death from COVID-19 between patients with RA and the general population according to their COVID-19 vaccination status. We used exposure score overlap weighting to balance baseline characteristics between 2 comparison cohorts. ResultsAmong unvaccinated individuals, the weighted incidence rates of SARS-CoV-2 infection (9.21 versus 8.16 of 1,000 person-months), hospitalization (3.46 versus 2.14 of 1,000 person-months), and death (1.19 versus 0.62 of 1,000 person-months) were higher among patients with RA than the general population over 3 months of follow-up; the corresponding adjusted hazard ratios (HRs) were 1.10 (95% confidence interval [95% CI] 1.00-1.24), 1.62 (95% CI 1.34-1.96), and 1.88 (95% CI 1.37-2.60), respectively. Among vaccinated individuals, the weighted rates of breakthrough infection (4.17 versus 3.96 of 1,000 person-months; HR 1.10 [95% CI 1.00-1.20]) and hospitalization (0.42 versus 0.32 of 1,000 person-months; HR 1.29 [95% CI 0.96-1.75]) were higher among patients with RA than the general population over 9 months of follow-up; however, no apparent difference in the risk of these outcomes was observed over 3 and 6 months of follow-up between 2 comparison cohorts. ConclusionPatients with RA are still at higher risks of SARS-CoV-2 infection and COVID-19 hospitalization than the general population after receiving COVID-19 vaccines. These findings support booster COVID-19 vaccinations and adherence of other preventive strategies among patients with RA.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Rheumatology

Efficacy and Safety of Tramadol for Knee or Hip Osteoarthritis: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials

Xiurui Zhang, Xiaoxiao Li, Yilin Xiong, Yilun Wang, Jie Wei, Chao Zeng, Tingting Sha, Guanghua Lei

Summary: This study evaluated the efficacy and safety of tramadol for knee and hip osteoarthritis. The results showed that tramadol 300 mg/day had minimal improvement in pain and function, but with increased adverse events compared to placebo. Therefore, the excessive use of tramadol is not recommended for treating knee and hip osteoarthritis.

ARTHRITIS CARE & RESEARCH (2023)

Article Rheumatology

Angiotensin receptor blockade is associated with increased risk of giant cell arteritis

Sizheng Steven Zhao, Houchen Lyu, Chao Zeng, Guanghua Lei, Jie Wei, Sarah L. Mackie

Summary: Initiation of ARBs is associated with a higher risk of GCA compared with ACEis or other antihypertensives. Mechanistic studies of angiotensin receptor biology will provide further clarity for our findings.

RHEUMATOLOGY (2023)

Article Rheumatology

Association of Sleep Deprivation and the Risk of Developing Systemic Lupus Erythematosus Among Women

May Y. Choi, Susan Malspeis, Jeffrey A. Sparks, Jing Cui, Kazuki Yoshida, Karen H. Costenbader

Summary: Sleep deprivation is associated with increased risk of autoimmune diseases, particularly systemic lupus erythematosus (SLE). This study using Nurses' Health Study data found that chronic low sleep duration was associated with higher risk of SLE, especially for individuals with bodily pain and depression.

ARTHRITIS CARE & RESEARCH (2023)

Article Rheumatology

Gout and Excess Risk of Severe SARS-CoV-2 Infection Among Vaccinated Individuals: A General Population Study

Dongxing Xie, Hyon K. Choi, Nicola Dalbeth, Zachary S. Wallace, Jeffrey A. Sparks, Na Lu, Chao Zeng, Xiaoxiao Li, Jie Wei, Guanghua Lei, Yuqing Zhang

Summary: This study found that individuals with gout, especially women, have higher risks of SARS-CoV-2 infection and severe outcomes, even when vaccinated.

ARTHRITIS & RHEUMATOLOGY (2023)

Article Rheumatology

Development and Validation of a Simulation Model for Treatment to Maintain Remission in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis

Zachary S. Wallace, John H. Stone, Xiaoqing Fu, Peter A. Merkel, Eli M. Miloslavsky, Yuqing Zhang, Hyon K. Choi, Emily P. Hyle

Summary: This study developed a simulation model (AAV-Sim) to predict clinical outcomes of fixed and tailored rituximab retreatment strategies in ANCA-associated vasculitis (AAV) patients. The model estimated transition rates, validated internally and externally, and produced consistent results with published data. The AAV-Sim has the potential to inform management guidelines and research priorities.

ARTHRITIS CARE & RESEARCH (2023)

Article Rheumatology

2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases

Anne R. Bass, Eliza Chakravarty, Elie A. Akl, Clifton O. Bingham, Leonard Calabrese, Laura C. Cappelli, Sindhu R. Johnson, Lisa F. Imundo, Kevin L. Winthrop, Reuben J. Arasaratnam, Lindsey R. Baden, Roberta Berard, S. Louis Bridges, Jonathan T. L. Cheah, Jeffrey R. Curtis, Polly J. Ferguson, Ida Hakkarinen, Karen B. Onel, Grayson Schultz, Vidya Sivaraman, Benjamin J. Smith, Jeffrey A. Sparks, Tiphanie P. Vogel, Eleanor Anderson Williams, Cassandra Calabrese, Joanne S. Cunha, Joann Fontanarosa, Miriah C. Gillispie-Taylor, Elena Gkrouzman, Priyanka Iyer, Kimberly S. Lakin, Alexandra Legge, Mindy S. Lo, Megan M. Lockwood, Rebecca E. Sadun, Namrata Singh, Nancy Sullivan, Herman Tam, Marat Turgunbaev, Amy S. Turner, James Reston

Summary: This study aims to provide evidence-based recommendations on vaccinations for patients with rheumatic and musculoskeletal diseases (RMDs). The research team conducted a systematic literature review and formulated guidelines on issues such as whether vaccinations can be administered during immunosuppressive treatment. Most recommendations have low quality of supporting evidence.

ARTHRITIS & RHEUMATOLOGY (2023)

Editorial Material Rheumatology

Preclinical or subclinical rheumatoid arthritis-associated interstitial lung disease: misleading terms with potentially deleterious consequences

Elizabeth R. Volkmann, Jeffrey A. Sparks, Anna-Maria Hoffmann-Vold, Tracy J. Doyle, Paul Emery, Philippe Dieude

LANCET RHEUMATOLOGY (2023)

Article Rheumatology

Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: a retrospective cohort study

Grace Qian, Xiaosong Wang, Naomi J. Patel, Yumeko Kawano, Xiaoqing Fu, Claire E. Cook, Kathleen M. M. Vanni, Emily N. Kowalski, Emily P. Banasiak, Katarina J. Bade, Shruthi Srivatsan, Zachary K. Williams, Derrick J. Todd, Michael E. Weinblatt, Zachary S. Wallace, Jeffrey A. Sparks

Summary: Outpatient SARS-CoV-2 treatment is associated with lower odds of severe COVID-19 outcomes in patients with systemic autoimmune rheumatic disease and COVID-19 compared with no outpatient treatment.

LANCET RHEUMATOLOGY (2023)

Article Medicine, General & Internal

Comparative effectiveness of BNT162b2 and ChAdOx1 nCoV-19 vaccines against COVID-19

Jie Wei, Weiya Zhang, Michael Doherty, Zachary S. Wallace, Jeffrey A. Sparks, Na Lu, Xiaoxiao Li, Chao Zeng, Guanghua Lei, Yuqing Zhang

Summary: In a population-based study in the UK, the BNT162b2 vaccine showed higher efficacy than the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 infection and hospitalization for COVID-19, but there was no significant difference in the risk of death from COVID-19.

BMC MEDICINE (2023)

Review Rheumatology

Acute and postacute COVID-19 outcomes for patients with rheumatoid arthritis: lessons learned and emerging directions 3 years into the pandemic

Alessandra Zaccardelli, Zachary S. Wallace, Jeffrey A. Sparks

Summary: This review summarizes the findings of studies on the outcomes of patients with rheumatoid arthritis (RA) and their risk of acute and postacute COVID-19. It is found that patients with RA have a higher risk of COVID-19 infection and severe outcomes, and factors such as immunosuppressive medications and disease severity contribute to the risk. Although COVID-19 vaccination reduces the risk for RA patients, some still experience breakthrough infections. Future studies are needed to investigate postacute sequelae of COVID-19 among RA patients.

CURRENT OPINION IN RHEUMATOLOGY (2023)

Article Rheumatology

Lowering Serum Urate With Urate-Lowering Therapy to Target and Incident Fracture Among People With Gout

Jie Wei, Hyon K. Choi, Nicola Dalbeth, Nancy E. Lane, Jing Wu, Houchen Lyu, Chao Zeng, Guanghua Lei, Yuqing Zhang

Summary: This study aimed to investigate whether lowering serum urate levels to target values through pharmacotherapy can reduce the risk of fractures in individuals with gout. The study found that lowering serum urate levels to target values was significantly associated with a decreased risk of fractures in individuals with gout.

ARTHRITIS & RHEUMATOLOGY (2023)

Article Public, Environmental & Occupational Health

The COVID-19 Pandemic and Daily Steps in the General Population: Meta-analysis of Observational Studies

Ziying Wu, Yilun Wang, Yuqing Zhang, Kim L. Bennell, Daniel K. White, Liusong Shen, Wei Ren, Jie Wei, Chao Zeng, Guanghua Lei

Summary: The COVID-19 pandemic has caused a decline in daily steps and physical activity levels. Studies show that over 7000 steps per day is the minimum standard for reducing the risk of all-cause mortality. The confinement period of COVID-19 has led to a significant decrease in daily steps among the general adult population.

JMIR PUBLIC HEALTH AND SURVEILLANCE (2023)

Letter Rheumatology

The Reply

April M. Jorge, Emma Materne, Baijun Zhou, Karen Costenbader, Yuqing Zhang, Hyon K. Choi

ARTHRITIS & RHEUMATOLOGY (2023)

No Data Available